221 related articles for article (PubMed ID: 23233725)
1. Antibody binding to Cryptococcus neoformans impairs budding by altering capsular mechanical properties.
Cordero RJ; Pontes B; Frases S; Nakouzi AS; Nimrichter L; Rodrigues ML; Viana NB; Casadevall A
J Immunol; 2013 Jan; 190(1):317-23. PubMed ID: 23233725
[TBL] [Abstract][Full Text] [Related]
2. Biological correlates of capsular (quellung) reactions of Cryptococcus neoformans.
MacGill TC; MacGill RS; Casadevall A; Kozel TR
J Immunol; 2000 May; 164(9):4835-42. PubMed ID: 10779792
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection.
Feldmesser M; Casadevall A
Front Biosci; 1998 Feb; 3():d136-51. PubMed ID: 9445465
[TBL] [Abstract][Full Text] [Related]
4. Rheological properties of cryptococcal polysaccharide change with fiber size, antibody binding and temperature.
de S Araújo GR; Viana NB; Pontes B; Frases S
Future Microbiol; 2019 Jul; 14():867-884. PubMed ID: 31340660
[No Abstract] [Full Text] [Related]
5. Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen.
Martinez LR; Moussai D; Casadevall A
Infect Immun; 2004 Jun; 72(6):3674-9. PubMed ID: 15155683
[TBL] [Abstract][Full Text] [Related]
6. Unexpected diversity in the fine specificity of monoclonal antibodies that use the same V region gene to glucuronoxylomannan of Cryptococcus neoformans.
McFadden DC; Casadevall A
J Immunol; 2004 Mar; 172(6):3670-7. PubMed ID: 15004170
[TBL] [Abstract][Full Text] [Related]
7. Contribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.
Duro RM; Netski D; Thorkildson P; Kozel TR
Clin Diagn Lab Immunol; 2003 Mar; 10(2):252-8. PubMed ID: 12626451
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance.
Zaragoza O; Casadevall A
Cell Microbiol; 2006 Dec; 8(12):1862-76. PubMed ID: 16824038
[TBL] [Abstract][Full Text] [Related]
9. A role for LHC1 in higher order structure and complement binding of the Cryptococcus neoformans capsule.
Park YD; Shin S; Panepinto J; Ramos J; Qiu J; Frases S; Albuquerque P; Cordero RJ; Zhang N; Himmelreich U; Beenhouwer D; Bennett JE; Casadevall A; Williamson PR
PLoS Pathog; 2014 May; 10(5):e1004037. PubMed ID: 24789368
[TBL] [Abstract][Full Text] [Related]
10. A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans.
Probert M; Zhou X; Goodall M; Johnston SA; Bielska E; Ballou ER; May RC
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670549
[TBL] [Abstract][Full Text] [Related]
11. High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library.
Beenhouwer DO; May RJ; Valadon P; Scharff MD
J Immunol; 2002 Dec; 169(12):6992-9. PubMed ID: 12471134
[TBL] [Abstract][Full Text] [Related]
12. Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide.
Rivera J; Mukherjee J; Weiss LM; Casadevall A
J Immunol; 2002 Apr; 168(7):3419-27. PubMed ID: 11907100
[TBL] [Abstract][Full Text] [Related]
13. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection.
Fleuridor R; Lees A; Pirofski L
J Immunol; 2001 Jan; 166(2):1087-96. PubMed ID: 11145689
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies.
Mukherjee J; Kozel TR; Casadevall A
J Immunol; 1998 Oct; 161(7):3557-68. PubMed ID: 9759877
[TBL] [Abstract][Full Text] [Related]
15. Antibody interactions with the capsule of Cryptococcus neoformans.
Feldmesser M; Rivera J; Kress Y; Kozel TR; Casadevall A
Infect Immun; 2000 Jun; 68(6):3642-50. PubMed ID: 10816523
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to keyhole limpet hemocyanin cross-react with an epitope on the polysaccharide capsule of Cryptococcus neoformans and other carbohydrates: implications for vaccine development.
May RJ; Beenhouwer DO; Scharff MD
J Immunol; 2003 Nov; 171(9):4905-12. PubMed ID: 14568972
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody mediated capsular reactions (Quellung) in Cryptococcus neoformans.
Mukherjee J; Cleare W; Casadevall A
J Immunol Methods; 1995 Jul; 184(1):139-43. PubMed ID: 7622865
[TBL] [Abstract][Full Text] [Related]
18. [Recognition of intact cells from Cryptococcus neoformans by the anti-glucuronoxylomannan 4B3 monoclonal antibody].
Gato Armas R; Martínez Machín G; Rodríguez Sánchez H; Otero González A; Sarracent Pérez J; Illnait Zaragozi MT
Rev Cubana Med Trop; 2006; 58(2):159-61. PubMed ID: 23427436
[TBL] [Abstract][Full Text] [Related]
19. Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.
De Jesus M; Nicola AM; Rodrigues ML; Janbon G; Casadevall A
Eukaryot Cell; 2009 Jan; 8(1):96-103. PubMed ID: 18952901
[TBL] [Abstract][Full Text] [Related]
20. Immunoelectronmicroscopic characterization of monoclonal antibodies (MAbs) against Cryptococcus neoformans.
Todaro-Luck F; White EH; Reiss E; Cherniak R
Mol Cell Probes; 1989 Dec; 3(4):345-61. PubMed ID: 2482437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]